Shude Cui
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 8
- Cancer Diagnosis and Treatment 3
-
- Breast Cancer Treatment Studies 13
- Cancer Genomics and Diagnostics 2
- Co-authors
- Zhenzhen Liu (12 shared papers)Hengwei Zhang (8 shared papers)Chongjian Zhang (7 shared papers)Min Yan (10 shared papers)Huijie Fan (1 shared paper)Qin Li (1 shared paper)Dechuang Jiao (6 shared papers)Jian-Hua Qiao (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Oncotarget (2 papers)Scientific Reports (2 papers)Journal of Clinical Oncology (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shude Cui
39 papers receiving 636 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 202
- Oncology 199
- Biomaterials 69
- Pulmonary and Respiratory Medicine 112
- Molecular Biology 214
Countries citing papers authored by Shude Cui
This map shows the geographic impact of Shude Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shude Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shude Cui more than expected).
Fields of papers citing papers by Shude Cui
This network shows the impact of papers produced by Shude Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shude Cui. The network helps show where Shude Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Shude Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 94 | |
| 2 | 2019 | 69 | |
| 3 | 2011 | 52 | |
| 4 | 2022 | 51 | |
| 5 | 2012 | 47 | |
| 6 | 2014 | 44 | |
| 7 | 2013 | 43 | |
| 8 | 2020 | 40 | |
| 9 | 2015 | 20 | |
| 10 | 2015 | 20 | |
| 11 | Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer. | 2015 | 17 |
| 12 | 2015 | 15 | |
| 13 | 2013 | 14 | |
| 14 | 2018 | 13 | |
| 15 | 2014 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2014 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2023 | 7 |
About Shude Cui
Shude Cui is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 42 papers that have together received 648 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (8 papers), Brain Metastases and Treatment (4 papers), Cancer Diagnosis and Treatment (3 papers), Breast Lesions and Carcinomas (3 papers), Cancer Genomics and Diagnostics (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (202 citations), Oncology (199 citations), Biomaterials (69 citations), Pulmonary and Respiratory Medicine (112 citations) and Molecular Biology (214 citations). Shude Cui has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhenzhen Liu, Hengwei Zhang, Chongjian Zhang, Min Yan, Huijie Fan, Qin Li, Dechuang Jiao, Jian-Hua Qiao, Tao Sun and Xuhui Guo. Their work appears in journals such as European Journal of Cancer, Oncotarget, Scientific Reports, Journal of Clinical Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.